Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
COSCIENS Biopharma Inc. (T.CSC) had Profit Margin of -138.14% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-14.48M |
|
-- |
|
-- |
|
-- |
|
-14.93M |
|
-- |
|
-14.46M |
|
-14.46M |
|
-14.48M |
|
-14.48M |
|
-14.48M |
|
-14.48M |
|
-14.93M |
|
-13.43M |
|
3.17M |
|
3.17M |
|
-4.57 |
|
-4.57 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
29.95M |
|
-- |
|
-- |
|
-- |
|
24.58M |
|
5.37M |
|
5.37M |
|
5.37M |
|
3.18M |
|
| Cash Flow Statement Financials | |
-11.84M |
|
-0.64M |
|
-0.57M |
|
22.91M |
|
10.21M |
|
-12.70M |
|
-0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.18 |
|
-- |
|
-- |
|
0.33 |
|
0.56 |
|
35.30% |
|
-142.45% |
|
-142.45% |
|
-128.11% |
|
-138.01% |
|
|
Profit Margin |
-138.14% |
-12.49M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
3.71 |
|
5.95 |
|
61.38 |
|
-269.60% |
|
-269.60% |
|
-48.33% |
|
-179.33% |
|
1.69 |
|
-3.95 |
|
-3.74 |
|